CompletedNot Applicable

Graftless Technique in Open Maxillary Sinus Lifting Using PEEK Versus Ti -Meshwork

Egypt12 participantsStarted 2024-05-03

Plain-language summary

The aim of the study is to assess the amount of bone formation with PEEK (intervention group) in comparison with Titanium Meshwork (control group) in maxillary sinus lifting using CBCT and assessment of the biocompatibility of the Meshwork and PEEK with the schniederian membrane integrity.

Who can participate

Age range

25 Years – 50 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * • Posterior edentulous ridges with pneumatized maxillary sinus and remaining bone height of 3 to 6 mm. * Patient age ranges from 25 to 50 years. * ASA physical status I and II. * Patients willing to be a part of the study and ready to give their consent in writing for the same. * Patient not complains from maxillary sinusitis * Patients are free from T.M.J disorders, abnormal oral habits such as bruxism. * Patient with good oral hygiene. Exclusion Criteria: * • Untreated gingivitis, periodontitis. * Subjected to irradiation in the head and neck area less than 1 year before implantation. * Untreated periodontitis. * Insufficient oral hygiene and motivation. * Pregnant or nursing. * Bone pathology. * Patient with blood disease. * Patient with any systematic disease that may affect normal healing. * Active infection or severe inflammation in the area intended for implant placement. * Treated or under treatment with intravenous amino-bisphosphonates.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Bone quantity

Timeframe: at 6 months of maxillary sinus lifting

Trial details

NCT IDNCT06846632

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-03

View on ClinicalTrials.gov More Maxillary Sinus trials

Who can participate

Age range

25 Years – 50 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.